Table 2: Mean ganglion cell - inner plexiform layer thickness parameters in diabetic patients compared with healthy controls.
| Parameters | Patients with diabetes | Controls | p value |
|---|---|---|---|
| Number of cases (n) | 60 | 60 | |
| Average GCIPL | 80.56 ± 7.97 | 83.70 ± 5.93 | 0.002 |
| Minimum GCIPL | 74.56 ± 12.25 | 80.51 ± 6.00 | 0.000 |
| Superotemporal GCIPL | 80.08 ± 7.29 | 82.71 ± 5.67 | 0.004 |
| Superor GCIPL | 81.94 ± 9.92 | 84.71 ± 6.51 | 0.017 |
| Superonasal GCIPL | 81.08 ± 10.30 | 85.01 ± 7.06 | 0.013 |
| Inferonasal GCIPL | 79.99 ± 9.36 | 83.45 ± 7.02 | 0.009 |
| Inferior GCIPL | 79.44 ± 10.00 | 82.58 ± 6.97 | 0.020 |
| Inferotemporal GCIPL | 80.75 ± 8.21 | 83.81 ± 5.80 | 0.013 |
| Central macular thickness | 253.15 ± 23.15 | 256.13 ± 18.05 | 0.053 |
GCIPL: Ganglion Cell-Inner Plexiform Layer.